000 01746 a2200517 4500
005 20250517100547.0
264 0 _c20170825
008 201708s 0 0 eng d
022 _a1523-5866
024 7 _a10.1093/neuonc/now086
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChang, Ken
245 0 0 _aMultimodal imaging patterns predict survival in recurrent glioblastoma patients treated with bevacizumab.
_h[electronic resource]
260 _bNeuro-oncology
_c12 2016
300 _a1680-1687 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAngiogenesis Inhibitors
_xtherapeutic use
650 0 4 _aBevacizumab
_xtherapeutic use
650 0 4 _aBiomarkers
650 0 4 _aBrain Neoplasms
_xdiagnostic imaging
650 0 4 _aDiffusion Magnetic Resonance Imaging
_xmethods
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aGlioblastoma
_xdiagnostic imaging
650 0 4 _aHumans
650 0 4 _aImage Interpretation, Computer-Assisted
650 0 4 _aMagnetic Resonance Imaging
_xmethods
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMultimodal Imaging
_xmethods
650 0 4 _aProportional Hazards Models
650 0 4 _aSurvival Analysis
650 0 4 _aTumor Burden
700 1 _aZhang, Biqi
700 1 _aGuo, Xiaotao
700 1 _aZong, Min
700 1 _aRahman, Rifaquat
700 1 _aSanchez, David
700 1 _aWinder, Nicolette
700 1 _aReardon, David A
700 1 _aZhao, Binsheng
700 1 _aWen, Patrick Y
700 1 _aHuang, Raymond Y
773 0 _tNeuro-oncology
_gvol. 18
_gno. 12
_gp. 1680-1687
856 4 0 _uhttps://doi.org/10.1093/neuonc/now086
_zAvailable from publisher's website
999 _c26087003
_d26087003